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Abstract
Background: Chronic kidney disease (CKD) is becoming a major public health problem around the world. But the
prevalence has not been reported in South Asian region as a whole. This study aimed to systematically review the
existing data from population based studies in this region to bridge this gap.
Methods: Articles published and reported prevalence of CKD according to K/DOQI practice guideline in eight South
Asian countries between December 1955 and April 2017 were searched, screened and evaluated from seven electronic
databases using the PRISMA checklist. CKD was defined as creatinine clearance (CrCl) or GFR less than 60 ml/min/1.73 m2.
Results: Sixteen population-based studies were found from four South Asian countries (India, Bangladesh, Pakistan and
Nepal) that used eGFR to measure CKD. No study was available from Sri Lanka, Maldives, Bhutan and Afghanistan.
Number of participants ranged from 301 in Pakistan to 12,271 in India. Majority of the studies focused solely on urban
population. Different studies used different equations for measuring eGFR. The prevalence of CKD ranged from 10.6% in
Nepal to 23.3% in Pakistan using MDRD equation. This prevalence was higher among older age group people. Equal
number of studies reported high prevalence among male and female each.
Conclusions: This systematic review reported high prevalence of CKD in South Asian countries. The findings of this study
will help pertinent stakeholders to prepare suitable policy and effective public health intervention in order to reduce the
burden of this deadly disease in the most densely populated share of the globe.
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Background
Globally, Chronic Kidney Disease (CKD) is one of the
leading causes of death and disability. In 1990, CKD was
the 27th leading cause of death which rose up and became
18th leading cause of death in 2010 [1]. In 2013, around 1
million people died because of CKD related cause [2].
Despite of being a global concern, CKD disproportionately
affects the people from developing countries. A systematic
review, conducted in 2015 reported that, 109.9 million
people from high-income countries had CKD (men-48.3
million, women-61.7 million) whereas the burden was
387.5 million in lower-middle income countries
(men-177.4 million, women- 210.1 million) [3].
CKD is associated with a wide range of life threatening
diseases [4]. CKD is considered as one of the major risk
factors for developing cardiovascular disease [5]. A study
conducted in 2003 reported that patients having Glomeru-
lar filtration rate (GFR) between 15 and 59 ml/min/
1.73 m2 are at 38% higher risk of development of cardio-
vascular disease than patients having GFR 90 and 150 ml/
min/1.73m2 [6]. Along with the impact on individual
health, CKD also affects the social life and responsible for
loss of productivity [7]. The most common form of social
impact due to CKD is financial burden [7]. CKD patients
are at higher risk to develop end-stage renal disease
(ESRD) which requires costly management like dialysis
and kidney transplantation [8]. A study conducted in USA
revealed that the treatment cost for CKD and ESRD im-
poses a huge financial burden to the health care system
and the average annual cost for end-stage renal disease
without transplantation was near 75 billion US dollar in
2001 [8]. CKD needs to be given priority because it is the
* Correspondence: mehedihasan6376@gmail.com
†Mehedi Hasan, Ipsita Sutradhar and Rajat Das Gupta contributed equally to
this work.
1Centre for Non-Communicable Diseases and Nutrition, BRAC James P Grant
School of Public Health, BRAC University, 5th Floor (Level-6), icddrb Building,
68 Shahid Tajuddin Ahmed Sarani, Mohakhali, Dhaka 1212, Bangladesh
Full list of author information is available at the end of the article
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Hasan et al. BMC Nephrology          (2018) 19:291 
https://doi.org/10.1186/s12882-018-1072-5
consequence of uncontrolled diabetes and hypertension
that are considered as world wide epidemic now a days.
Despite the acute and chronic harmful consequences,
CKD is hardly studied specially in lower and middle in-
come countries of Asia and Africa. Few segregated
studies have been conducted in India, Bangladesh,
Pakistan, Nepal, and Sri Lanka, however, no systematic
review is available in South Asian region portraying the
current burden of CKD. Hence, it is difficult for policy
makers and public health leaders to get a complete
scenario about CKD burden in these countries and for-
mulate relevant policies to overcome CKD related mor-
tality and morbidity. Therefore, we have conducted this
systematic review to identify the prevalence of CKD in
South Asian countries.
Methods
Search strategy
We conducted a systematic review of relevant existing
literatures from South Asian countries using PRISMA
guideline [9]. Two researchers separately searched the
potential literatures in PubMed, Google Scholar, and
POPLINE. In addition, they searched national online
journal for India, Pakistan, Bangladesh, Nepal, and Sri
Lanka. However, no national online journal was available
for Bhutan, Maldives and Afghanistan. During search,
medical sub-heading as well as plain text were used for
the following keywords: ‘epidemiology’, ‘prevalence’,
‘chronic renal insufficiency’, ‘chronic kidney disease’, ‘India’,
‘Bangladesh’, ‘Sri Lanka’, ‘Nepal’, ‘Bhutan’, ‘Maldives’, ‘Pakistan’
and ‘Afghanistan’. Using those key terms together with
Boolean operators, global search term was developed for
potential literature search. We also manually searched the
bibliography of all selected studies (snow bowling) to iden-
tify more articles.
Inclusion and exclusion criteria
Inclusion criteria for this study were a) study reported
data from South Asian countries; b) study published be-
tween December 1955 (earliest publication) and 30,
April 2017; c) study reported prevalence of CKD; d)
study published in English language; and e) study carried
out in general population. Exclusion criteria for this
study were a) study did not report data from South
Asian countries; b) study published in other languages
than English; c) conference proceedings, book chapters,
editorials, and study published only in abstract form;
d) study carried out in high risk group of people
(known case of diabetes, hypertension, kidney disease);
e) study with a sample size of less than 200 partici-
pants; and f ) study did not determine CKD based on
GFR estimation by serum creatinine-based equations.
At first, two researchers (IS and RDG) searched and
screened all the articles individually. The third
researcher (MH) critically reviewed the overall search
and screening process to ensure the consistency. Finally,
the full text of selected publications was assessed for eligi-
bility by all three researchers (MH, RDG, and IS). Any dis-
crepancies were resolved by group (MH, IS, RDG and
MS) consensus throughout the whole process.
Quality appraisal
Three researchers (MH, IS and RDG) independently
determined risk of bias of included studies. For this pur-
pose, we adopted a quality assessment checklist where
eight study characteristics were used to assess the quality
of included studies such as selection of representative
study participants, sample size, sampling technique, re-
sponse rate, exclusion rate and method used for determin-
ation of CKD. This checklist was prepared based on the
criteria used in a systematic review on CKD conducted in
Sub-Saharan Africa [10]. If the study participants were
representative of the general population, we scored it as
“2”, however, if the study participants were representative
of the population in question, we scored it as “1” other-
wise we scored it as “0”. If the study participants were not
included or excluded on the basis of specific risk factors,
sample size was adequate (at least 384 considering 50%
prevalence rate), sampling technique was random, re-
sponse rate was > 40%, exclusion rate was < 10%, methods
used to diagnose CKD was mentioned, consistent method
for determination of CKD was used, we scored articles as
“1”, however, if the study participants were included or ex-
cluded on the basis of specific risk factors, sample size was
not adequate, sampling technique was non-random, re-
sponse rate was ≤ 40%, exclusion rate was ≥ 10%, methods
used to diagnose CKD was not mentioned and consistent
method for determination of CKD was not used, we
scored articles as “0”. Later, the number for each study
was added to get the final score. The maximum score was
9. If any study gets 7–9, we considered it as “high quality”
study. Score 4, 5 and 6 were considered as “moderate
quality” study, and score 0, 1, 2 and 3 were considered as
“poor quality” study. All the discrepancies that arouse
while quality assessment were solved by consensus.
Definition of CKD
Chronic Kidney Disease (CKD) is defined as the struc-
tural/functional abnormalities of kidney or decreased
GFR < 60 ml/min/1.73 m2 for 3 months [11]. We used the
definition of CKD from the K/DOQI practice guideline
that was published in 2002 by the National Kidney
Foundation (NKF). CKD was defined as creatinine
clearance (CrCl) or GFR less than 60 ml/min/1.73 m2
[11, 12]. In the included studies for this review, three
equations were used to estimate eGFR: Four-variable
MDRD equation [13, 14], CKD-EPI equation [15] and
Cockcroft-Gault equation [16].
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Data extraction
Two authors (MH and RDG) separately extracted data
from the selected articles and for this purpose a data ex-
traction table was developed in excel file. This table in-
cluded (a) title, (b) journal name, (c) name of authors,
(d) publication year, (e) year of data collection, (f ) study
objective, (g) study setting (urban/rural), (h) study design,
(i) sampling strategy (random/non-random), (j) sample
size, (k) study population, (l) outcome assessment (object-
ive/subjective), (m) diagnostic criteria for CKD, (n) preva-
lence (overall), (o) prevalence (gender, age, location
specific), and (p) authors’ conclusion. After data extrac-
tion, a third author (IS) crosschecked both of the tables
to ensure consistency. Any dispute that arose during
data extraction was resolved by group consensus. Sub-
sequently, data was analyzed using tabulation, grouping
and thematic approach.
Result
Search result
The initial search brought up 3906 articles. After removal
of duplication, 3031 articles were eligible to be screened
by title and abstract. Following title and abstract screen-
ing, 79 studies remained for full text assessment. Then 63
studies were excluded after full text review. Finally 16 arti-
cles met the eligibility criteria and were reviewed and
synthesized (Fig. 1) [17–32]. Articles on CKD were
found from India (n = 8), Pakistan (n = 4), Bangladesh
(n = 3), and Nepal (n = 1). No study was found from Sri
Lanka, Bhutan, Afghanistan and Maldives. Most of the
studies were published after 2010 except one Indian
and one Pakistani study published in 2009 and 2005
respectively [20, 30]. Numbers of participants ranged
from 301 in a study from Pakistan [29] to 12, 271 in an
Indian study [17].
Quality of studies and risk of bias
Among the 16 studies included in our systematic review,
nine were of high quality [17, 18, 20, 21, 25, 26, 28, 30, 31]
and seven were of moderate quality [19, 22–24, 27, 29, 32]
based on the preselected criteria described in ‘Quality ap-
praisal’ section. Detail of the study quality is illustrated in
Additional file 1. Closer inspection of the table shows, the
study participants were representative of the general
population in seven studies [17, 20, 25, 28, 30–32] and
representative of the population in question for nine
studies [18, 19, 21–24, 26, 27, 29]. No study included or
excluded participants on the basis of specific risk factors.
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Fig. 1 Flowchart showing steps of selecting articles
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Sample size was adequate in 13 studies [17–24, 26, 27,
30–32] and sampling technique was random in eight
studies [17, 18, 20, 25, 27, 28, 30, 31]. Twelve studies
reported response rate as > 40% [17, 18, 20, 21, 23–26,
28–31] and five studies reported exclusion rate as < 10%
[20, 21, 26, 29, 31]. All the 16 studies used a consistent
method for determination of CKD and reported the
method used [17–32]. Study data were neither sufficient
nor homogeneous to allow for meta-analyses.
Description of studies: design, setting and population
India
We found eight studies from India, all of which adopted
cross-sectional study design [17–24]. Majority of the stud-
ies were done exclusively in urban settings [17, 19, 21, 23,
24], however, only one study was conducted involving par-
ticipants from both urban, semi urban and rural areas
[20]. Three of these studies recruited participants using
random sampling technique [17, 18, 20]. Number of re-
spondents in these studies ranged from 1104 to 12,271
and majority of them were adult male (Table 1) [19–23].
The studies measured spot quantitative urine protein and/
or eGFR as biomarker for determination of CKD. Three
studies used MDRD equation [19, 21, 22]; one study used
CKD-EPI equation [17] and two studies used both [23, 24]
to calculate eGFR. Rest of the studies used both CG-BSA
and MDRD formula [18, 20].
Bangladesh
Three studies were identified from Bangladesh [25–27],
of which all were conducted in Dhaka city (capital of
Bangladesh). Two studies performed community based
survey [25, 27] of which one targeted slum dwellers
[27]. These two studies selected participants using
random sampling technique [25, 27]. However, Fatema et
al. carried out their study among participants attending a
health screening camp and their sampling technique
was non-random [26]. The number of participants in
Bangladeshi studies ranged from 402 to 1000. Male
were predominant in two studies (51.0%, 88.3%) [25, 26].
One study recruited participants from people who were
older than 30 years [25]. However, in rest of the two
studies, lower age limit was 15 years and 18 years
(Table 2) [26, 27].
In these studies, eGFR was measured using MDRD
[26, 27], CG [26] and CKD-EPI equation [25].
Pakistan
We found four studies from Pakistan and all of those
studies were conducted in urban areas of Karachi [28–31].
Three out of four studies performed community based
survey and selected participants using random sampling
technique [28, 30, 31]. However, Imran et al., conducted
study among volunteers who willingly participated in a
health camp and sampling technique of this study was
non-random [29]. Amidst three Pakistani studies, lowest
Table 1 Characteristics of the Indian studies
Author [ref.], year Setting Study population, study design, sampling strategy Number of participants, response, age limit
and mean age (±S.D.), gender
Anand et al. [17], 2015 Urban Participants from Delhi and Chennai who took part
in Center for Cardio metabolic Risk Reduction in
South Asia surveillance, cross sectional, random
12,271, 80%, > 20 years, mean age ± S.D.:
41.4 ± 12.7 years (Chennai), 44.4 ± 13.9
years (Delhi), 43.5% male
Anupama et al. [18], 2014 Rural Participants from rural Karnataka who took part in
a screening survey, cross sectional study, random
2728, 76.6%, ≥18 years, mean age ± S.D.:
39.88 ± 15.87 years, 45.6% male
Mahapatra et al. [19], 2016 Urban Indian central government Employees in Delhi,
cross sectional study, non-random
1104, Not mentioned, > 18 years,
Not Mentioned, 61.4% male
Singh et al. [20], 2009 Urban, Semi
Urban, Rural
Participants from Delhi and adjoining region,
cross sectional, random
5563, 94.4%, ≥ 20 years, Not Mentioned,
60% male
Singh et al. [21], 2013 Urban Participants attending thirteen academic and
private medical centers in India participated in
the study under the name of Screening and
Early Evaluation of Kidney disease – SEEK, cross
sectional study, non-random
6120, 92.3%, ≥18 years, mean age ± S.D.:
45.22 ± 15.2 years, 55.1% male
Trivedi et al. [22], 2016 Semi Urban Participants attending a health screening camp
in six towns of India, cross sectional study,
non-random
2350, Not Mentioned, mean age ± S.D.:
48.16 ± 14 years, 61.2% male
Varma et al. [23], 2010 Urban Indian central government employees in Agra
town, cross sectional study, Not Mentioned
3398, 83.9% ≥18 years, mean age ± S.D.:
35.64 ± 8.72 years, 66% male
Varma et al. [24], 2011 Urban Indian Army personnel in Agra town who were
part of ‘Comprehensive Health Survey for
Detection of Life Style Diseases at the
local Military Hospital., cross sectional study,
Not Mentioned
1920, 81.9%, > 20 years, mean age ± S.D.:
34.72 ± 7.57 years, gender distribution
Not Mentioned
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and highest sample size was 301 [29] and 3143 respect-
ively [31]. Minimum age requirement was 15 years [28] to
40 years [31] in these studies. eGFR was measured using
MDRD [28, 30], CKD-EPI [29] and CKD-EPI Pakistan
equation [31] in Pakistani studies.
Nepal
Only one article was available from Nepal that carried
out population based study to identify CKD (according
to K/DOQI guideline) prevalence. This study adopted
community-based cross sectional survey design and was
conducted in urban Dharan [32]. One thousand individ-
uals (male-48%, female-52%) who were at least 20 years
old participated in this survey (Table 2) [32]. This study
measured eGFR using MDRD equation for diagnosis of
CKD [32].
Prevalence of CKD
India
The overall pooled prevalence of CKD among Indian
adults was 10.2%. As per high quality studies, highest
prevalence was 17.2% found among participants of
SEEK (Screening and Early Evaluation of Kidney Dis-
ease) study [21] and lowest prevalence was 4.2% found
among ≥ 20 years old adult residing in Delhi [20]. Singh
et al. (MDRD-17.2%, CKD EPI-16.4%) and Varma et al.
(MDRD-15%, CKD EPI-13.1%) found that CKD preva-
lence was slightly higher while using MDRD equation
compared to that found using CKD-EPI equation [21, 23].
Studies that used both MDRD and CG-BSA equations
found that the prevalence of CKD was markedly higher
using CG-BSA equation than that found using MDRD
equation (Anupama et al.: MDRD-6.3%, CG/BSA-16.69%;
MDRD-4.2%, CG/BSA-13.3%) (Table 3) [18, 20].
Age-specific prevalence: Three studies from India
reported age-specific prevalence of CKD. Two studies
reported the age specific prevalence using MDRD equa-
tion and the rest one used CKD-EPI equations. All of
these studies found that prevalence of CKD rose with in-
creasing age (Table 3) [17, 18, 22].
Gender specific prevalence: Six Indian studies reported
gender specific CKD prevalence.Three out of these six
studies reported higher prevalence of CKD among men
ranged between 8.1% and 21.0% [18, 21, 22]. However,
rest three studies reported that the CKD prevalence was
higher among female participants ranged between 16.3%
and 19.1% than their male counterparts [17, 18, 20, 23]
(Table 3).
Bangladesh
The overall pooled prevalence of CKD among Bangla-
deshi adults was 17.3%. As per high quality studies, in
Bangladesh, highest prevalence of CKD was reported as
26.0% [25] whereas Fatema et al. reported the lowest
prevalence (12.8%) [26] (Table 4). This discripency might
be attributable to the age difference of study participants
in these two studies. Mean age of study participants
were 49.5 years and 37 years in Anand et al. [25] and
Table 2 Characteristics of the studies from Bangladesh, Pakistan and Nepal
Author [ref.], year Setting Study population, study design, sampling strategy Number of participants, response, age
limit and mean age (±S.D.), gender
Bangladesh:
Anand et al. [25], 2014 Urban Participants from urban Dhaka, cross sectional
study, random
402, 88.8%, > 30 years, mean age ± S.D.:
49.5 ± 12. 7 years, 51% male
Fatema et al. [26], 2013 Urban Participants attending a health screening camp
in urban Dhaka, cross sectional study, non-random
650, 97.5%, 18–70 years, mean age ± S.D.:
37 ± 11 years, 88.3% male
Huda et al. [27], 2012 Urban Participants from urban slum of Dhaka, cross
sectional study, random
1000, not mentioned, 15–65 years, mean
age ± S.D.: 34.39 ± 12.70 years, 33% male
Nepal:
Sharma et al. [32], 2013 Urban Participants from community-based screening
for Chronic Kidney Disease, Hypertension and
Diabetes in urban Dharan, cross sectional study,
non-random
1000, not mentioned, ≥20 years, not
mentioned, 48% male
Pakistan:
Alam et al. [28], 2014 Urban Participants from urban Karachi, cross sectional
study, random
461, 76%, ≥15 years, not mentioned,
36% male
Imran et al. [29], 2015 Urban Volunteers who willingly gave their sample in
a health camp in urban Karachi, cross sectional
study, non-random
301, 97.3%, 30–80 years, not mentioned,
62% male
Jafar et al. [30], 2005 Urban Participants from urban Karachi, cross sectional
study, random
332, 88.9%, > 40 years, mean age ± S.D.:
51.4 ± 9.9 years, 54.2% male
Jessani et al. [31], 2014 Urban Participants from urban Karachi, cross sectional
study, random
3143, 91.4%, ≥ 40 years, not mentioned,
47.8% male
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Table 3 Prevalence of CKD in India
Author [ref.], year Assessment of Kidney Function Prevalence of CKD
Anand et al. [17], 2015 Spot quantitative urine protein
and eGFR (CKD-EPI)
Overall: 7.5% (crude), 8.7%
after age standardization
Age and Gender specific prevalence:
Chennai:
Male: 6.6% Female: 6.5% (crude)
Male: 7.5% Female: 7.7% (age standardized)
Age in years Male Female
20–44 3.5% 4.6%
45–64 10.7% 10.5%
≥65 21.6% 16.7%
Delhi:
Male: 8.1% Female: 9.4% (crude)
Male: 9.0% Female: 10.8% (age standardized)
Age in years Male Female
20–44 5.1% 6.6%
45–64 9.5% 12.0%
≥65 29.4% 28.9%
Anupama et al. [18], 2014 Spot quantitative urine protein,
creatinine clearance and eGFR
(CG/BSA & MDRD)
Overall: 6.3% (MDRD),
16.69% (CG/BSA)
Age specific prevalence:
Age in Years Prevalence
18–19 0.8%
20–29 2.4%
30–39 3.8%
40–49 6.4%
50–59 7.5%
60–69 16.7%
≥70 21%
Gender specific prevalence:
Male: 8.1% Female: 4.8% (MDRD)
Mahapatra et al. [19], 2016 Spot quantitative urine protein
and eGFR (MDRD)
Overall: 27.7% Age specific prevalence:
Not Mentioned
Gender specific prevalence:
Not Mentioned
Singh et al. [20], 2009 Spot quantitative urine protein
and eGFR (MDRD, CG/BSA)
Overall: 13.3% (CG/BSA),
4.2% (MDRD)
Age specific prevalence:
Not Mentioned
Gender specific prevalence:
Male: 11.1% Female: 16.6% (CG/BSA)
Male: 2.7% Female: 6.3% (MDRD)
Singh et al. [21], 2013 Spot quantitative urine protein
and eGFR (MDRD)
Overall: 17.2% (MDRD),
16.4% (CKD-EPI)
Age specific prevalence:
Not Mentioned
Gender specific prevalence:
Male: 19% Female: 14.9% (MDRD)
Trivedi et al. [22], 2016 Spot quantitative urine protein
and eGFR (MDRD)
Overall: 20.93% Age specific prevalence:
Age in Years Prevalence
18–30 18.53%
31–40 13.74%
41–50 20.52%
51–60 20.93%
61–70 26.77%
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Fatema et al. [26] respectively. The only study that fo-
cused on urban slum dwellers, CKD prevalence was
found as 16.0% using CG/BSA method (Table 5) [27].
Age-specific prevalence: Among the three Bangladeshi
studies, only Huda et al. reported age specific prevalence
of CKD. According to this study, the prevalence of CKD
was higher among elderly people aged more than 40 years
(16.5%) than their counterparts whose age was between
25 years and 40 years (10.7%) (Table 5) [27].
Gender specific prevalence: Two studies from Bangladesh
reported gender segregated prevalence of CKD [25, 27].
Anand et al. reported that the prevalence of CKD was
higher among women (28.0%) than men (24.7%) [25],
however, Huda et al. identified more male (14.3%) to suf-
fer from CKD than their female counterparts (12.7%)
(Table 5) [27].
Pakistan
The overall CKD prevalence among Pakistani adults was
21.2%. According to high quality studies, highest CKD
prevalence in Pakistan was reported as 29.9% [30] and
the lowest prevalence was 12.5% [31]. Though both of
these studies were conducted among similar age group
participants, use of different equations for determining
CKD might be attributable to this difference.
Age-specific prevalence: Among the Pakistani studies,
only Alam et al. reported age specific prevalence of
CKD. The study found highest prevalence of CKD
among elderly participants having age more than 50 years
(43.6%) and lowest prevalence among comparatively
younger participants aged less than 30 years (10.5%)
(Table 5) [28].
Gender specific prevalence: All the four Pakistani stud-
ies reported gender specific prevalence of CKD [28–31].
Alam et al. and Imran et al. reported higher CKD preva-
lence among men [28, 29], however, Jessani et al. and Jafar
et al. identified women to suffer from CKD more fre-
quently than men [30, 31]. In the high quality study that
used country specific equation for determining CKD,
slightly higher proportion of female participants were
found to have CKD than their male counterparts
(male-11.6%, female-13.3%) (Table 4) [31].
Nepal
Only one Nepalese study met eligibility criteria for
this systematic review [32]. This moderated quality
study was conducted among ≥20 years old adults res-
iding in urban Dharan and reported CKD prevalence
as 10.6%. While segregated by age, CKD prevalence
has shown rising trend with increasing age (Table 4).
However, gender specific prevalence was not mentioned
in this study.
Discussions
To the best of our knowledge, our systematic review is
the first of this type that portrayed the prevalence of
CKD in South Asian countries. This study will, expect-
antly, bring attention of international, regional as well as
Table 3 Prevalence of CKD in India (Continued)
Author [ref.], year Assessment of Kidney Function Prevalence of CKD
> 70 36.36%
Gender specific prevalence:
Male: 21% Female: 20.8%
Age in Years Prevalence
Male Female
18–30 18.5% 18.58%
31–40 11.63% 16%
41–50 20.06% 21.13%
51–60 22.83% 17.62%
61–70 25.33% 30%
> 70% 31.48 58.33%
Varma et al. [23], 2010 Spot quantitative urine protein
and eGFR (CKD-EPI & MDRD)
Overall: 15% (MDRD),
13.1% (CKD-EPI)
Age specific prevalence:
Not Mentioned
Gender specific prevalence:
Male: 12.62% Female: 14.13% (CKD-EPI)
Male: 13.04% Female: 19.13% (MDRD)
Varma et al. [24], 2011 Spot quantitative urine protein
and eGFR (CKD-EPI & MDRD)
Overall: 9.54% Age specific prevalence:
Not Mentioned
Gender specific prevalence:
Not Mentioned
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national stakeholders to the magnitude of CKD and im-
portance of reducing burden of this deadly disease in the
most densely populated share of the globe.
It was reveled from our study that there is a scarcity of
population based data on CKD in South Asian countries.
This finding approves the statement of a previous study
that reported that data on non-communicable diseases
are rarely available outside developed countries [33].
Ample inconsistencies in characteristics of study popula-
tion, study design, sampling technique and methods
used to determine CKD makes it challenging to depict
exact figure of CKD prevalence as well as to offer per-
suasive comparison of prevalence estimates in these
countries.
Nevertheless, according to the existing literature, one
to four out of every 10 individuals in South Asia are suf-
fering from CKD. Highest and lowest prevalence of CKD
was reported from Pakistan (21.2%) and India (10.2%)
respectively. The country specific prevalence of India,
Bangladesh and Nepal is similar with the global preva-
lence of CKD (13.4%) [34] and with the prevalence in
some developed countries like the USA and Japan (10%
to 13%) [35, 36]. However, the unusually high prevalence
reported in Pakistan might be due to higher minimum
age requirement set as eligibility criteria of study partici-
pants in Pakistani studies (> 40 years). The age specific
distribution of CKD unveiled from this systematic review
also supports this finding. Studies from four different
countries (India, Bangladesh, Pakistan and Nepal) re-
vealed that the prevalence of CKD was higher among
elderly people than their younger counterparts. Age is a
well-established risk factor for development of CKD [37, 38].
Usually, as a part of the normal physiologic process, renal
function (GFR) starts to decline even in a healthy individual
after 30 to 40 years of age, which might deteriorate after
50–60 years of age due to structural changes in kidneys
[39, 40]. This increased prevalence of CKD among elderly
individuals also can be explained by the higher prevalence
of diabetes and hypertension among this group of people
that are considered as important risk factors for develop-
ing CKD [17, 28, 29, 32].
Seven studies included in our review found higher
prevalence of CKD among men whereas rest of the studies
reported that women suffer from CKD more frequently
Table 4 Prevalence of CKD in South Asian countries according to the quality of primary studies
Author [ref.], year Study quality Prevalence of CKD Study site Required age of study participants Mean age (± S.D.) of
study participants
India:
Anand et al. [17], 2015 High 8.7% Urban > 20 years 41.4 ± 12.7 years (Chennai),
44.4 ± 13.9 years (Delhi)
Anupama et al. [18], 2014 High 6.3% (MDRD),
16.69% (CG/BSA)
Rural ≥ 18 years 39.88 ± 15.87 years
Mahapatra et al. [19], 2016 Moderate 27.7% Urban > 18 years Not Mentioned
Singh et al. [20], 2009 High 4.2% (MDRD),
13.3% (CG/BSA)
Urban, Semi
Urban, Rural
≥ 20 years Not Mentioned
Singh et al. [21], 2013 High 17.2% (MDRD),
16.4% (CKD-EPI)
Urban ≥ 18 years 45.22 ± 15.2 years
Trivedi et al. [22], 2016 Moderate 20.93% Semi Urban Not Mentioned 48.16 ± 14 years
Varma et al. [23], 2010 Moderate 15% (MDRD),
13.1% (CKD-EPI)
Urban ≥ 18 years 35.64 ± 8.72 years
Varma et al. [24], 2011 Moderate 9.54% Urban > 20 years 34.72 ± 7.57 years
Bangladesh:
Anand et al. [25], 2014 High 26% Urban > 30 years 49.5 ± 12. 7 years
Fatema et al. [26], 2013 High 12.8% Urban 18–70 years 37 ± 11 years
Huda et al. [27], 2012 Moderate 13.1% (MDRD),
16% (CG/BSA)
Urban 15–65 years 34.39 ± 12.70 years
Nepal:
Sharma et al. [32], 2013 Moderate 10.6% Urban ≥ 20 years Not Mentioned
Pakistan:
Alam et al. [28], 2014 High 16.6% Urban ≥ 15 years Not Mentioned
Imran et al. [29], 2015 Moderate 25.6% Urban 30–80 years Not Mentioned
Jafar et al. [30], 2005 High 29.9% Urban > 40 years 51.4 ± 9.9 years
Jessani et al. [31], 2014 High 12.5% Urban ≥ 40 years Not Mentioned
Hasan et al. BMC Nephrology          (2018) 19:291 Page 8 of 12
than men. This finding is in contrast with the pattern of
gender distribution of CKD across the globe. In a recently
conducted systematic review on global prevalence of
CKD, two-third of included studies identified that CKD
was more prevalent in women than in men [34]. A
population-based study conducted in Norway reported
that female gender was associated with slower decline of
GFR with increasing age [41]. Women are also considered
protected from CKD to some extent because of their dis-
tinctive biological phenomenon (glomerular structure,
glomerular hemodynamics systolic blood pressure, hormo-
nal status) and life style related factors (dietary protein and
Table 5 Prevalence of CKD in Bangladesh, Pakistan and Nepal
Author [ref.], year Assessment of Kidney Function Prevalence of CKD
Bangladesh:
Anand et al. [25], 2014 Spot quantitative urine protein
and eGFR (CKD-EPI)
Overall: 26% Age specific prevalence:
Not Mentioned
Gender specific prevalence:
Male: 24.7% Female: 28%
Fatema et al. [26], 2013 Spot quantitative urine protein
and eGFR (MDRD)
Overall: 12.8% Age specific prevalence:
Not Mentioned
Gender specific prevalence:
Not Mentioned
Huda et al. [27], 2012 Spot quantitative urine protein,
creatinine clearance and eGFR
(CG/BSA & MDRD)
Overall: 13.1% (MDRD),
16% (CG/BSA)
Age specific prevalence (MDRD):
25–40 Years: 10.7%
> 40 Years: 16%
Gender specific prevalence (MDRD):
Male: 14.7% Female: 12.3%
Nepal:
Sharma et al. [32], 2013 Spot quantitative urine protein
and eGFR (MDRD)
Overall: 10.6% Age specific prevalence:
Age in years Prevalence
20–39 3.4%
40–59 11.4%
≥ 60 30.5%
Gender specific prevalence:
Not Mentioned
Pakistan:
Alam et al. [28], 2014 Spot quantitative urine protein
and eGFR (MDRD)
Overall: 16.6% Age specific prevalence:
Age in Years Prevalence
< 30 10.5%
30–50 12.7%
> 50 43.6%
Gender specific prevalence:
Male: 20.6% Female: 14.2%
Imran et al. [29], 2015 eGFR (CKD-EPI) Overall: 25.6% Age specific prevalence:
Not Mentioned
Gender specific prevalence:
Male: 26.3% Female: 22.4%
Jafar et al. [30], 2005 Creatinine clearance and eGFR
(MDRD)
Overall: 29.9% Age specific prevalence:
Not Mentioned
Gender specific prevalence:
Male: 26.7% Female: 32.5%
Jessani et al. [31], 2014 Spot quantitative urine protein
and eGFR (CKD-EPI Pakistan
equation)
Overall: 12.5% Age specific prevalence:
Not Mentioned
Gender specific prevalence:
Male: 11.6% Female: 13.3%
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salt intake, smoking and alcohol consumption) [42, 43].
However, further research is needed to identify gender
specific prevalence of CKD in South Asian countries.
This systematic review indicates that CKD poses a
huge burden on the health system of South Asian coun-
tries (India, Bangladesh, Pakistan and Nepal). This is not
unusual considering the high prevalence of diabetes and
hypertension in this region [44–50]. However, awareness
on different non-communicable diseases like diabetes,
hypertension and CKD is very little among South Asian
people and people usually do not seek health care until
any sign or symptom of CKD appears [44, 45, 51]. In
addition, people commonly prefer self-treatment or rely
on informal and unqualified practitioners [52–54]. Like
other LMICs, health system of South Asian countries
are not prepared to combat the huge burden of NCDs
[55]. Number human resources dedicated for prevention
and treatment of kideny dieseases is also less and dispro-
portonate in these countries [55]. Along with these, poor
referral system prevailing in South Asian countries makes
it difficult to detect CKD cases in early stage [56–58]. It is
evident that untreated CKD is a risk factor for developing
end stage renal disease (ESRD) and cardiovascular dis-
eases (CVDs) that are leading causes of death in LMICs
[59–62]. CKD is also found to be associated with poor
health-related quality of life and loss of productivity [63].
To combat the CKD related burden, prevention and early
detection of the disease through low-cost community
based screening programs is important especially in re-
source constrain settings of South Asian countries. It is
also a timely need for pertinent stakeholders of these
countries to perform advocacy in order to offer low cost
kidney transplantation and dialysis facility for advanced
stage CKD patients. Further research is warranted to iden-
tify actual burden of CKD among people of different age
group, sex, ethnicity and geographical location as well as
among underprivileged group of people residing in slums
and rural areas.
This systematic review is not free from limitations.
The main limitation of this review was equations used
for determining CKD by included studies were not vali-
dated amid South Asian population except one study
carried out by Jessani et al. [31]. Moreover, studies con-
sidered for this review adopted cross-sectional design,
though, to be declared as having CKD, one person needs
to show abnormal kidney structure or function for more
than 3 months, which cannot be captured by cross sec-
tional studies [64].
Conclusions
Chronic Kidney Disease is a major public health con-
cern in South Asian countries. Studies reported that
one to four out of every ten individuals in these coun-
tries are suffering from CKD with variation attributable
to discrepancy in research methodology and methods
used for determining CKD. Prevalence of CKD rose with
increasing age, however issues such as gender and other
socio-economic factors have not been explored fully,
therefore, further research is warranted. Limited number
of population-based studies using cross-sectional design
also created the need for further research to identify actual
burden of CKD and its distribution in these countries. It is
also a timely need for relevant stakeholders of this region
to develop suitable policy and effective public health inter-
vention for prevention, control and treatment of CKD in
South Asia.
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